RAMM Pharma Overview

  • Year Founded
  • 1988

Year Founded

  • Status
  • Public

  • Stock Symbol
  • RAMM

Stock Symbol

  • Investments
  • 7

RAMM Pharma General Information

Description

RAMM Pharma Corp is engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The group generates revenue from the sale of medical devices and consumables, the sale of pharmaceutical products, and sale of cosmetics. Geographically, it derives a majority of its revenue from Uruguay.

Contact Information

Formerly Known As
MTC Growth Fund-I
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 82 Richmond Street East
  • Suite 200
  • Toronto, Ontario M5C 1P1
  • Canada
+1 (416)
Primary Industry
Other Pharmaceuticals and Biotechnology
Stock Exchange
CNQ
Corporate Office
  • 82 Richmond Street East
  • Suite 200
  • Toronto, Ontario M5C 1P1
  • Canada
+1 (416)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RAMM Pharma Stock Performance

As of 18-Nov-2026, RAMM Pharma’s current market cap is $835K with 119M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.01 $835K 119M 71.2K -$0.05

RAMM Pharma Financials Summary

As of 31-Jul-2026, RAMM Pharma has a trailing 12-month revenue of $916K.

In Thousands,
USD
TTM 31-Jul-2026 FY 2025 31-Oct-2025 FY 2024 31-Oct-2024 FY 2023 31-Oct-2023
EV 798 922 (48) 51
Revenue 916 2,396 3,190 3,753
EBITDA (6,032) (5,649) (11,223) (4,828)
Net Income (6,551) (6,352) (12,123) (5,721)
Total Assets 4,795 6,630 12,042 23,356
Total Debt 121 57 135 293
Public Fundamental Data provided by Morningstar, Inc. disclaimer

RAMM Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore RAMM Pharma‘s full profile, request access.

Request a free trial

RAMM Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
RAMM Pharma Corp is engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and p
Other Pharmaceuticals and Biotechnology
Toronto, Canada

Toronto, Canada

Toronto, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

RAMM Pharma Competitors (2)

One of RAMM Pharma’s 2 competitors is Mandara Pharma, a Corporation company based in Toronto, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mandara Pharma Corporation Toronto, Canada
Avicanna Formerly VC-backed Toronto, Canada
You’re viewing 2 of 2 competitors. Get the full list »

RAMM Pharma Investments & Acquisitions (7)

RAMM Pharma’s most recent deal was a Merger/Acquisition with HemPoland for . The deal was made on 06-Sep-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
HemPoland 06-Sep-2022 Merger/Acquisition Personal Products
Canapar 14-Jun-2021 Merger/Acquisition Cultivation
Canapar 04-Jan-2021 Corporate Cultivation
Canapar 30-Dec-2020 Secondary Transaction - Private Cultivation
NettaLife 04-Jun-2020 Merger/Acquisition Other Consumer Non-Durables
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

RAMM Pharma ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Food Products

Industry

Rank

Percentile

Packaged Foods

Subindustry

Rank

Percentile

To view RAMM Pharma’s complete esg history, request access »

RAMM Pharma Exits (1)

RAMM Pharma’s most recent exit was on 03-May-2019 from Medicplast. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Medicplast 03-May-2019 Completed
To view RAMM Pharma’s complete exits history, request access »

RAMM Pharma Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
HemPoland Elblag, Poland 2014

RAMM Pharma FAQs

  • When was RAMM Pharma founded?

    RAMM Pharma was founded in 1988.

  • Where is RAMM Pharma headquartered?

    RAMM Pharma is headquartered in Toronto, Canada.

  • What industry is RAMM Pharma in?

    RAMM Pharma’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is RAMM Pharma a private or public company?

    RAMM Pharma is a Public company.

  • What is RAMM Pharma’s stock symbol?

    The ticker symbol for RAMM Pharma is RAMM.

  • What is the current market cap of RAMM Pharma?

    The current market capitalization of RAMM Pharma is $835K.

  • What is RAMM Pharma’s current revenue?

    The trailing twelve month revenue for RAMM Pharma is $916K.

  • Who are RAMM Pharma’s competitors?

    Mandara Pharma and Avicanna are competitors of RAMM Pharma.

  • What is RAMM Pharma’s annual earnings per share (EPS)?

    RAMM Pharma’s EPS for 12 months was -$0.05.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process